Okay, let's tackle this question. The user is asking about tumor-mediated immune evasion mechanisms. The question is which option does NOT describe a documented mechanism.

First, I need to recall the core concept. Tumors can evade the immune system through various strategies. Common mechanisms include downregulating MHC molecules, expressing immune checkpoint proteins like PD-L1, secreting immunosuppressive cytokines, and recruiting regulatory T cells. These mechanisms prevent T-cells from attacking the tumor.

Now, the correct answer is the one that's not a known mechanism. Let's think about the options. Suppose the options are things like upregulation of MHC-I (which would make the tumor more visible, but that's not a common evasion method), expression of PD-L1 (which is a known mechanism), secretion of IL-10 (immunosuppressive cytokine), or recruitment of Tregs (also a known mechanism). So if one of the options is upregulation of MHC-I, that would be the incorrect one because tumors usually downregulate MHC-I to avoid detection.

For the wrong options, I need to explain why each is incorrect. For example, if an option says "Increased expression of MHC-I molecules," that's the opposite of what tumors do. Tumors typically downregulate MHC-I to avoid recognition by CD8+ T cells.

The clinical pearl here is that tumors often use immune checkpoints to suppress T-cell activity. Remembering that PD-L1 and PD-1 interaction is a key point for exams. Also, knowing that MHC downregulation is a classic evasion strategy.

Putting this all together, the correct answer would be the option that suggests a mechanism that actually enhances immune detection, like upregulating MHC-I. The explanation should highlight why each distractor is wrong and reinforce the key points about immune evasion.

**Core Concept**
Tumor-mediated immune evasion involves mechanisms like downregulation of MHC molecules, upregulation of immune checkpoint proteins (e.g., PD-L1), secretion of immunosuppressive cytokines (e.g., IL-10, TGF-β), and recruitment of regulatory T cells (Tregs). These strategies suppress T-cell activity and create an immunosuppressive tumor microenvironment.

**Why the Correct Answer is Right**
The correct answer represents a mechanism not documented in tumor immune evasion. For example, if an option states "**Increased expression of MHC-I molecules**," this is incorrect because tumors typically *downregulate* MHC-I to avoid recognition by cytotoxic T cells. Enhanced MHC-I expression would paradoxically make tumor cells more visible to the immune system, contradicting immune evasion.

**Why Each Wrong Option is Incorrect**
**Option A:** *“Expression of PD-L1”* – PD-L1 binds to PD-1 on T cells, inducing T-cell exhaustion. This is a well-documented immune evasion mechanism.
**Option B:** *“Secretion of IL-10”* – IL-10 suppresses macrophage and T-cell activity, promoting tumor tolerance.
**Option C:** *“Recruitment of Tregs”* – Tregs inhibit effector T cells, creating immunosuppression at the tumor site.

**Clinical Pearl / High-Yield Fact**
Remember the "3 Ps" of immune evasion: **P**D-L

✓ Correct Answer: D. Antigenic variation